ENTITY
Molecular Partners AG

Molecular Partners AG (MOLN SW)

Health CareSwitzerland
Molecular Partners AG develops and markets biopharmaceutical products. The Company develops designed ankyrin repeat protein platform therapies used in ophthalmology, oncology, inflammation, and other therapeutic treatments. Molecular Partners serves healthcare professionals and patients internationally.
more
Company Presentation12 Nov 2025 23:00
Company Presentation31 Oct 2025 04:00
Company Presentation25 Aug 2025 15:00
Company Presentation16 May 2025 19:00
Company Presentation07 Mar 2025 21:00
x